Search

Your search keyword '"ANTIPSYCHOTIC agents"' showing total 1,008 results

Search Constraints

Start Over You searched for: Descriptor "ANTIPSYCHOTIC agents" Remove constraint Descriptor: "ANTIPSYCHOTIC agents" Journal acta psychiatrica scandinavica Remove constraint Journal: acta psychiatrica scandinavica
1,008 results on '"ANTIPSYCHOTIC agents"'

Search Results

1. The risk of diabetes and HbA1c deterioration during antipsychotic drug treatment: A Danish two‐cohort study among patients with first‐episode schizophrenia.

2. Dosing levels of antipsychotics and mood stabilizers in bipolar disorder: A Nationwide cohort study on relapse risk and treatment safety.

3. Treatment of postpartum psychotic‐ or mood disorder requiring admission: A nationwide study from Denmark.

4. Comparative responses to 17 different antidepressants in major depressive disorder: Results from a 2‐year long‐term nation‐wide population‐based study emulating a randomized trial.

5. Demographic and clinical characteristics of lithium-treated older adults with bipolar disorder.

6. Antipsychotic agents in anxiety disorders: An umbrella review.

7. Antipsychotics in the maintenance phase for psychotic depression.

8. Use of antipsychotics and antidepressants in first‐episode psychotic depression: A nationwide register‐based study.

9. Antipsychotic drugs and risk of acute pancreatitis: A nationwide case–control study.

10. Maintenance treatment of psychotic depression: Is antipsychotic medication needed?

11. Antipsychotics and obsessive–compulsive disorder/obsessive–compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system.

12. Neurodevelopment in school‐aged children after intrauterine exposure to antipsychotics.

13. The metabolic adverse effects of antipsychotic use in individuals with intellectual and/or developmental disability: A systematic review and meta‐analysis.

14. Characteristics and predictors of off‐label use of antipsychotics in general population sample.

15. Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real‐World Observational Study.

16. The risk of dementia in patients using psychotropic drugs: Antidepressants, mood stabilizers or antipsychotics.

17. Clozapine treatment and risk of severe COVID‐19 infection.

18. A nationwide nested case‐control study of new‐onset obsessive‐compulsive disorder following antipsychotics use in schizophrenia.

19. Adiposity in schizophrenia: A systematic review and meta‐analysis.

20. A systematic review and pooled, patient‐level analysis of predictors of mortality in neuroleptic malignant syndrome.

21. Clozapine and mortality: A comparison with other antipsychotics in a nationwide Danish cohort study.

22. How and when to treat the most common adverse effects of antipsychotics: Expert review from research to clinical practice.

23. Neurodevelopment in school-aged children after intrauterine exposure to antipsychotics

24. Weight gain on antipsychotics – A perfect storm of complex pathophysiology and psychopharmacology.

25. Clozapine treatment in a wider context: From before eligibility to life beyond clozapine.

26. How to treat mania.

27. Adherence to clozapine vs. other antipsychotics in schizophrenia.

28. Antipsychotic medication exposure, clozapine, and pneumonia: results from a self‐controlled study.

29. Effect of age on the relative efficacy of clozapine in schizophrenia.

30. Three‐year longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder.

31. Exposure to risperidone versus other antipsychotics and risk of osteoporosis‐related fractures: a population‐based study.

32. Twenty‐year medication use trends in first‐episode bipolar disorder

33. The metabolic adverse effects of antipsychotic use in individuals with intellectual and/or developmental disability: A systematic review and <scp>meta‐analysis</scp>

34. Symptomatic versus disease‐modifying effects of psychiatric drugs

35. Antipsychotic drugs and risk of acute pancreatitis: A nationwide case–control study

36. Multi‐trajectories of antidepressant and antipsychotic use: a 11‐year naturalistic study in a community‐based sample.

37. Medication adherence in first episode psychosis: the role of pre‐onset subthreshold symptoms.

38. Placebo effects in adult and adolescent patients with schizophrenia: combined analysis of nine RCTs.

39. Impact of CYP1A2 genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and meta‐analysis.

40. Childhood trauma and treatment outcomes during mood‐stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder

41. Comparative effectiveness and safety of antipsychotic drugs in patients with schizophrenia initiating or reinitiating treatment: A Real‐World Observational Study

42. Antipsychotic utilization trajectories three years after initiating or reinitiating treatment of schizophrenia: A state sequence analysis approach

43. The validity and sensitivity of PANSS‐6 in treatment‐resistant schizophrenia.

44. Increased number of monocytes and plasma levels of MCP‐1 and YKL‐40 in first‐episode psychosis.

45. Demographic and clinical characteristics of patients who recommence clozapine following therapy interruptions

46. A nationwide nested case‐control study of new‐onset obsessive‐compulsive disorder following antipsychotics use in schizophrenia

47. Management of depression in patients with schizophrenia spectrum disorders: a critical review of international guidelines.

48. Clozapine as a first‐ or second‐line treatment in schizophrenia: a systematic review and meta‐analysis.

49. Long-term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality.

50. No differences in olanzapine- and risperidone-related weight gain between women and men: a meta-analysis of short- and middle-term treatment.

Catalog

Books, media, physical & digital resources